HRT FINANCIAL LP - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 225 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 12.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2024$817
+76.8%
18,608
+85.0%
0.01%0.0%
Q3 2023$462
+33.5%
10,057
+66.8%
0.01%
+66.7%
Q2 2023$346
-71.1%
6,029
-81.1%
0.00%
-80.0%
Q1 2023$1,198
+142.0%
31,947
+80.6%
0.02%
+114.3%
Q4 2022$495
-99.9%
17,693
+43.4%
0.01%
+40.0%
Q2 2022$429,000
+57.7%
12,340
-13.8%
0.01%
+150.0%
Q3 2021$272,000
-62.5%
14,315
-60.3%
0.00%
-71.4%
Q2 2021$726,000
+178.2%
36,048
+209.3%
0.01%
-12.5%
Q2 2020$261,00011,6540.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
MQS Management LLC 10,935$255,0000.41%
GLOBEFLEX CAPITAL L P 144,692$3,370,0000.34%
CORNERCAP INVESTMENT COUNSEL INC 58,975$1,374,0000.20%
Factorial Partners, LLC 10,900$254,0000.17%
FEDERATED HERMES, INC. 3,464,335$80,684,0000.15%
Campbell & CO Investment Adviser LLC 14,800$345,0000.12%
FULLER & THALER ASSET MANAGEMENT, INC. 611,462$14,241,0000.08%
Summit Global Investments 45,900$1,069,0000.07%
RENAISSANCE GROUP LLC 63,559$1,480,0000.06%
PDT Partners, LLC 33,459$779,0000.06%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders